This message was sent to ##Email##
|
|
|
The Wall Street Journal
The U.S. Food and Drug Administration recently said it approved Eli Lilly's drug to treat a form of the most common type of lung cancer.
Portrazza can be used in combination with two forms of chemotherapy to treat patients with advanced squamous non-small-cell lung cancer who haven't previously received medication specifically for treating their advanced lung cancer. Portrazza, or necitumumab, is a monoclonal antibody that blocks activity of EGFR, a protein commonly found on squamous NSCLC tumors.
READ MORE
Reuters
Mindfulness-based therapy may help ease anxiety and depression in some patients with cancer, a small research review suggests.
As medical advances have helped transform cancer from a death sentence to a chronic disease for many patients, more attention is being paid to the physical and mental health problems that can linger even after tumors subside.
READ MORE
Oncology Nurse Advisor
The impact on prostate-specific antigen screening and prostate cancer incidence before and after the release of the 2012 U.S. Preventive Services Task Force screening recommendations was examined in two studies published in JAMA. Ahmedin Jemal, DVM, PhD, of the American Cancer Society, Atlanta, and colleagues examined trends in stage-specific prostate cancer incidence and PSA-based screening for men 50 years and older subsequent to the 2008 and 2012 USPSTF recommendations using the most recent population-based incidence and nationally representative screening data.
READ MORE
CoC
If you are affiliated with a CoC-accredited program, please make sure that program responds to the Call for Data to ensure compliance with CoC Standards 5.5 (Data Submission), 5.6, (Accuracy of Data) and requirements for submission deadline extensions. Read this announcement from the NCDB to learn more.
University of Delaware via Medical Xpress
Cancer cells are continuously produced in our bodies, where most of them are recognized by our immune systems and destroyed. Some, however, escape this innate surveillance system and find a place to survive and grow. Several factors expelled by tumor cells are concentrated in the area immediately surrounding the tumor, called the tumor microenvironment. While it is established that these factors support and enhance cancer cell growth and multiplication, it was not known whether these factors influence neighboring normal cells.
READ MORE
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text.
|
|
ACS
It is not too late! You may purchase the Webcast packages to view the sessions you were not able to attend at Clinical Congress. Webcast sessions are available on your computer, tablet or mobile device anytime, anywhere. Maximize your learning opportunities and earn CME Credit and Self-Assessment Credit when it's convenient for you. Click here to see more.
TIME
China will likely see an increase in the prevalence of lung cancer among its population over the next five years, the state-run China Daily reports. Medical experts told the paper that over 800,000 annual diagnoses and 700,000 annual deaths can be expected by 2020.
READ MORE
Managed Healthcare Executive
New payment models that were initially developed for primary care or common surgical procedures are now being developed and used for patients with blood diseases.
READ MORE
CQIP 2015 now available (CoC-accredited programs only)
|
   |
CoC
The National Cancer Data Base (NCDB) is pleased to announce the release of the Cancer Quality Improvement Program (CQIP) 2015. The CQIP report is unique in providing not only short-term quality and outcome data, but also long-term outcome data including five-year survival rates for commonly treated malignancies stratified by stage. CQIP allows each CoC-accredited program access to a confidential and individualized report, in PowerPoint format, to allow programs the ability to modify the presentations and select topic-based slides to review in meetings as needed. CQIP is accessed through CoC Datalinks, under NCDB Reporting Tools; the CQIP Reports link will provide access to the three most recent CQIP reports, allowing programs to assess changes in their reports over time. The column named "Reporting Year" distinguishes each CQIP report.
TIME
Since 1994, scientists have known that mutations in the BRCA gene can contribute to a higher risk of developing breast and ovarian cancers. But for the first time, researchers say that the gene may also play a part in the nerve death that's responsible for Alzheimer's disease.
READ MORE
Scientific American
Birds and certain bird bits — their beaks, their feathers, their livers — are involved in traditional remedies throughout the world, practices that trace back to Mesopotamia, ancient Egypt and early China. It turns out birds may play a helpful role in modern western medicine too. A new study suggests that the common pigeon can reliably distinguish between benign versus malignant tumors and, in doing so, could help researchers develop better cancer screening technologies.
READ MORE
CoC
The Commission on Cancer (CoC), a Quality Program of the American College of Surgeons, is launching the Oncology Medical Home (OMH) Accreditation Program. The OMH uses a team-based approach to deliver, ensure and measure quality cancer care. It's a comprehensive patient-focused system that can be designed to meet the needs of patients, payers and providers. The OMH's goal is to provide better access to care and treat patients outside of the acute care hospital setting.
READ MORE
Kyoto University via Medical Xpress
Ovarian cancer is the seventh most common cancer among women worldwide, and it often goes undetected until it has spread to other parts of the body. More than 70 percent of ovarian cancer patients experience relapse; when recurrent cancers become resistant to chemotherapy, they become extremely difficult to treat. But what if patients could make use of their own immune system?
READ MORE
ACS
Follow the CoC (@COC_ACS) and the NAPBC (@NAPBC_ACS) on Twitter. Make sure you also like the NAPBC Facebook page.
READ MORE
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|